Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Financial Ratios
Indo US Bio-Tech Ltd.
BSE Code 541304
ISIN Demat INE250Z01010
Book Value (Rs) 41.50
NSE Code INDOUS
Dividend Yield % 0.17
Market Cap(Rs Mn) 2918.57
TTM PE(x) 16.39
TTM EPS(Rs) 8.88
Face Value (Rs) 10  
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)8.11  4.12  7.22  5.71  8.40  
   CEPS(Rs)8.66  4.51  4.02  3.09  3.67  
   DPS(Rs)0.25  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)39.16  31.29  54.35  42.41  35.47  
   Tax Rate(%)1.59  6.28  1.98  4.60  -23.53  
Margin Ratios          
   Core EBITDA Margin(%)18.24  14.83  15.21  13.85  13.75  
   EBIT Margin(%)17.35  14.17  13.91  13.37  13.24  
   Pre Tax Margin(%)15.92  12.09  11.96  10.97  10.29  
   PAT Margin (%)15.67  11.33  11.73  10.46  12.72  
   Cash Profit Margin (%)16.72  12.43  13.06  11.31  13.34  
Performance Ratios          
   ROA(%)17.98  10.81  11.67  10.63  13.05  
   ROE(%)23.03  14.08  15.51  17.34  26.87  
   ROCE(%)21.15  14.42  14.62  15.86  18.30  
   Asset Turnover(x)1.15  0.95  1.00  1.02  1.03  
   Sales/Fixed Asset(x)9.79  10.36  9.57  12.72  21.43  
   Working Capital/Sales(x)1.48  1.31  1.30  1.44  1.99  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.10  0.10  0.10  0.08  0.05  
   Receivable days59.84  109.71  133.85  164.93  207.92  
   Inventory Days215.16  197.06  148.59  128.48  95.73  
   Payable days597.69  -53.89  302.49  -222.52  0.00  
Valuation Parameters          
   PER(x)18.15  53.94  29.43  11.81  3.87  
   PCE(x)17.00  49.17  26.41  10.93  3.69  
   Price/Book(x)3.76  7.09  3.91  1.59  0.92  
   Yield(%)0.17  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)2.98  6.29  3.64  1.48  0.78  
   EV/Core EBITDA(x)16.21  41.20  23.84  10.45  5.60  
   EV/EBIT(x)17.19  44.39  26.14  11.11  5.86  
   EV/CE(x)3.32  5.95  3.40  1.35  0.72  
   M Cap / Sales2.84  6.11  3.45  1.24  0.49  
Growth Ratio          
   Net Sales Growth(%)42.56  17.96  23.36  24.86  0.82  
   Core EBITDA Growth(%)71.86  18.17  32.33  28.02  39.92  
   EBIT Growth(%)74.56  20.21  28.35  26.10  41.59  
   PAT Growth(%)97.15  13.96  38.25  2.73  101.13  
   EPS Growth(%)97.15  -43.02  26.40  -31.99  101.13  
Financial Stability Ratios          
   Total Debt/Equity(x)0.19  0.23  0.21  0.32  0.53  
   Current Ratio(x)5.31  4.19  4.87  3.85  2.12  
   Quick Ratio(x)0.98  1.22  2.68  1.94  1.46  
   Interest Cover(x)12.09  6.79  7.15  5.57  4.50  
   Total Debt/Mcap(x)0.05  0.03  0.05  0.20  0.58